Oral evidence transcripts

Inquiry E-cigarettes inquiry

Witnesses Rob Morrison, Senior Regulatory Policy Executive, Advertising Standards Authority, Professor John Newton, Director of Health Improvement, Public Health England, Professor Gillian Leng, Deputy Chief Executive, National Institute for Health and Care Excellence, and Dr Ian Hudson, Chief Executive, Medicines and Healthcare products Regulatory Agency; Steve Brine MP, Parliamentary Under-Secretary of State for Public Health and Primary Care, and Dr Tim Baxter, Deputy Director of Healthy Behaviours, Department of Health and Social Care

Inquiry E-cigarettes inquiry

Witnesses Michelle Jarman-Howe, Executive Director, Public Sector Prisons South, and Heather Thomson, Smokefree Lead, Nottinghamshire Healthcare NHS Foundation Trust; Deborah Arnott, Chief Executive, Action on Smoking and Health, and Hazel Cheeseman, Director of Policy, Action on Smoking and Health

Inquiry Flu vaccination programme inquiry

Witnesses Professor Paul Cosford, Director for Health Protection and Medical Director, Public Health England, Professor Steve Powis, National Medical Director, NHS England, Professor Jonathan Van-Tam, Deputy Chief Medical Officer, Professor Andrew Pollard, Chair, Joint Committee on Vaccination and Immunisation, and Dr Sue Crossland, President Elect, Society for Acute Medicine

Inquiry E-cigarettes inquiry

Witnesses Dr Ian Jones, Vice President, Reduced-Risk Products, Japan Tobacco International, Dr Chris Proctor, Chief Scientific Officer, British American Tobacco, Dr Moira Gilchrist, Vice President, Scientific and Public Communications, Philip Morris Limited, and Dr Grant O’Connell, Regulatory and Scientific Affairs, Fontem Ventures; Professor David Harrison, Chair of the UK Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC), and Dr Lynne Dawkins, Associate Professor, Centre for Addictive Behaviours Research, London South Bank University

Inquiry Research integrity

Witnesses Professor Sir Mark Walport, Chief Executive, UK Research and Innovation

Inquiry Brexit science and innovation Summit inquiry

Witnesses Sam Gyimah MP, Minister for Universities, Science, Research and Innovation, and Amanda Dickins, Deputy Director, EU Exit: Science and Innovation, Department for Business, Energy and Industrial Strategy

Inquiry Biometric Strategy and Forensic Services inquiry

Witnesses Dr Gillian Tully, Forensic Science Regulator; Baroness Williams of Trafford, Minister for Countering Extremism, and Christophe Prince, Director for Data and Identity, Home Office

Inquiry Algorithms in decision-making inquiry

Witnesses Elizabeth Denham, Information Commissioner; Margot James MP, Minister for Digital and Creative Industries, Oliver Buckley, Deputy Director, Digital Charter and Data Ethics, and Andrew Elliot, Data Protection Bill Manager, Department for Digital, Culture, Media and Sport

Inquiry Algorithms in decision-making inquiry

Witnesses Dr Dominic King, Senior Staff Research Scientist and Clinical Lead, DeepMind Health, Dr Ian Hudson, Chief Executive, Medicines and Healthcare products Regulatory Agency (MHRA), Professor Harry Hemingway, Farr Institute of Health Informatics Research, and Eleonora Harwich, Head of Digital and Tech Innovation, Reform

Inquiry Pre-appointment hearing for MRC and UKRI Chairs inquiry

Witnesses Professor Fiona Watt, preferred candidate for Executive Chair, Medical Research Council, and Sir John Kingman, preferred candidate for Chair, UK Research and Innovation

Inquiry Research integrity

Witnesses Professor Sir Bernard Silverman, Chair of Trustees, and James Parry, Chief Executive, UK Research Integrity Office; Dr Tony Peatfield, Director of Corporate Affairs, Medical Research Council, and Chairman, RCUK Good Research Conduct Network, and Dr Steven Hill, Head of Research Policy, Higher Education Funding Council for England; Professor Jonathan Montgomery, Chair, Health Research Authority

Inquiry E-cigarettes inquiry

Witnesses Professor Peter Hajek, Professor of Clinical Psychology, Queen Mary University of London, Professor Mark Conner, Professor in Applied Social Psychology, University of Leeds, and Professor Riccardo Polosa, Professor of Internal Medicine, University of Catania; Dr Lion Shahab, Senior Lecturer Health Psychology, University College London, Dr Jamie Brown, Deputy Director, Tobacco and Alcohol Research Group University College London, and Professor Paul Aveyard, Co-ordinating Editor, The Cochrane Tobacco Addiction Group

Inquiry Algorithms in decision-making inquiry

Witnesses Martin Wattenberg, Senior Staff Research Scientist, Google AI team, Charles Butterworth, Managing Director for UK, Europe, Middle East and Africa, Experian, Dr. M-H. Carolyn Nguyen, Director of Technology Policy, Microsoft, and Nick Pickles, Head of Public Policy UK and Israel, Twitter; Sheena Urwin, Head of Criminal Justice, Durham Constabulary, and Professor Kate Bowers, Academic Director, UCL Jill Dando Institute

Inquiry Research integrity

Witnesses Dr Ivan Oransky, Co-Founder, Retraction Watch, and Distinguished Writer in Residence, New York University Arthur Carter Journalism Institute, and Professor C.K. Gunsalus, Director, US National Center for Professional and Research Ethics (via video-link); Dr Ben Goldacre, DataLab, Department of Primary Care, University of Oxford, Dr Simon Kolstoe, Senior Lecturer and University Ethics Advisor, University of Portsmouth, and Independent chair of Hampshire A (NHS) and MOD research ethics committees, and Síle Lane, Head of International Campaigns and Policy, Sense about Science

Inquiry Genomics and genome editing in the NHS inquiry

Witnesses Dr Hilary Burton, Consultant in Public Health, PHG Foundation, Professor Sian Ellard, Clinical Programme Director, South West NHS Genomic Medicine Centre, and Fiona Murphy, Director, National Services Division, NHS National Services Scotland, and Member of the Scottish Genomes Partnership; Lord O’Shaughnessy, Parliamentary Under-Secretary of State, Department of Health, Professor Dame Sally Davies, Chief Medical Officer for England, and Professor Patrick Chinnery, Professor of Neurology, Cambridge University

Inquiry Research integrity

Witnesses Professor David Hand, Royal Statistical Society, Dr Damian Pattinson, Vice President of Publishing Innovation, Research Square, and Wendy Appleby, Registrar and Head of Student & Registry Services, University College London; Dr Trish Groves, Director of Academic Outreach, BMJ, Dr Elizabeth Moylan, Senior Editor for Peer Review Strategy and Innovation, BioMedCentral (representing the Committee on Publication Ethics), Catriona Fennell, Director of Publishing Services, Elsevier (representing The Publishers Association), and Dr Alyson Fox, Director of Grants Management, Wellcome Trust

Inquiry Algorithms in decision-making inquiry

Witnesses Hetan Shah, Executive Director, Royal Statistical Society, Professor Nick Jennings, Royal Academy of Engineering, Dr Adrian Weller, Turing Fellow, Alan Turing Institute, and Professor Louise Amoore, Durham University; Silkie Carlo, Senior Advocacy Officer, Liberty, Dr Sandra Wachter, Lawyer and Researcher in Data Ethics, AI, and Robotics at the Oxford Internet Institute, and Dr Pavel Klimov, Chair of the Law Society’s Technology and the Law Group

Inquiry Research integrity

Witnesses Professor Dorothy Bishop, University of Oxford, Dr Arnaud Vaganay, Director, Meta-Lab, and Professor Dame Ottoline Leyser, former Chair, Steering Group on the Culture of Scientific Research, Nuffield Council on Bioethics; Dr Elizabeth Wager, Publications Consultant, Sideview, Professor Sir Ian Diamond, Universities UK Research Policy Network, Professor Ian Walmsley, Pro Vice Chancellor for Research Working Group, Russell Group, and Dr Peter Wilmshurst, Consultant Cardiologist, Royal Stoke University Hospital

Inquiry Science budget and Industrial Strategy inquiry

Witnesses Rebecca Endean, Strategy Director, UK Research and Innovation, Professor Richard Jones, Professor of Physics, University of Sheffield, Professor Paul Boyle, Chair, Research Policy Network, Universities UK, and Alun Evans, Chief Executive, British Academy; Dr Ruth McKernan, Chief Executive, Innovate UK, David Connell, Senior Research Fellow, Centre for Business Research, University of Cambridge, Tom Thackray, Director for Innovation, CBI, and Tom Morrison-Bell, Head of Public Affairs, techUK

Inquiry Genomics and genome editing in the NHS inquiry

Witnesses Dr Magdalini Papadaki, Head of Product and Process Innovation, Association of the British Pharmaceutical Industry, and Professor Sir John Bell, Regius Professor of Medicine, University of Oxford; Dr Mark Kroese, Chair, Diagnostics Advisory Committee, National Institute for Health and Care Excellence, Professor Sue Hill, Chief Scientific Officer for England, NHS England, and Professor William Newman, Vice Chair, British Society for Genetic Medicine